Lung Cancer Center, Phoenix

Your treatment options

Lung Cancer Center

Lung cancer often is diagnosed in the advanced stages. Because of the seriousness of the disease, it is important to turn to clinical experts with training and expertise in treating not just cancer, but lung cancer specifically. New treatments are constantly being developed in this era of precision, genomic-based cancer care, so finding a treatment plan that includes available innovations tailored to your tumor type, stage, genomic markers and other needs may be key to finding a treatment option that is best for you.

At Cancer Treatment Centers of America® (CTCA), Phoenix, our focus on lung cancer enables our oncologists to stay up to date on new and emerging treatments and technologies, helping you make informed decisions about the options available to treat the disease and manage its side effects. Your team of lung cancer experts collaborate daily, all under one roof, conferring with you and one another to develop a detailed treatment plan more quickly and efficiently. As part of our commitment to providing state-of-the-art lung cancer treatment options, we offer qualifying patients an opportunity to participate in ongoing clinical trials in immunotherapy, and other areas of innovation. Our Lung Cancer Center team will help you determine whether you are a candidate for an available study and, if so, help you enroll.

Our Lung Cancer Center doctors

Peter Baik

Thoracic Surgeon


Samuel Ejadi

Chief of Medical Oncology, CTCA Phoenix


Sagun Shrestha

Medical Oncologist, Hematologist


Mahmoud Mahafzah



Elesyia Outlaw-Evans

Chief of Radiation Oncology

Ali Suleiman

Suleiman Ali

Interventional Pulmonologist

Learn more

A comprehensive team approach

At the Lung Cancer Center at CTCA® Phoenix, our multidisciplinary cancer experts work together with a synergy that comes from dedicating their time and energies on a single mission—treating lung cancer patients. Each care team is led by a medical oncologist and coordinated by a care manager, who helps keep track of your appointments, follows up on tests and answers your medical questions. Our lung cancer pathologists are experienced and trained in advanced tools to diagnose and stage the disease to better pinpoint the array of treatment options available to you.

Depending on your needs, your care team may also include a surgical and/or radiation oncologist, pulmonologist, oncology nurses and supportive care clinicians who help you manage related side effects. As part of our integrative care model designed to help you stay strong during treatment, your care team may recommend a number of evidence-based supportive therapies, such as nutrition therapy, occupational therapy, naturopathic support and pain management. A nurse practitioner trained in smoking cessation techniques is also available to offer strategies for quitting tobacco for those who request it. The entire team works together with a “whole-person” focus, which is at the heart of our Lung Cancer Center's dedication to comprehensive, personalized care.

Lung cancer clinical trials

The Lung Cancer Center at CTCA Phoenix is dedicated to offering innovative, leading-edge treatment options. One way to do that is by offering carefully selected clinical trials in immunotherapy, chemotherapy and targeted therapies. Clinical trials are an essential testing ground for measuring the effectiveness of drugs and other treatments before they can win government approval. Trials may offer participants new options that would otherwise be unavailable to them.

Learn more about our clinical trials.

Clinical trials Q&A

Who may benefit from lung cancer clinical trials?

Each lung cancer patient is considered on a case-by-case basis. This is a time of rapid scientific advances in lung cancer treatment. New surgical techniques are designed to remove lung tumors while reducing the amount of trauma to healthy tissue. Meanwhile, a new generation of lung cancer therapies is being developed to attack tumors that have specific genomic mutations. These new targeted treatments may be more effective and cause fewer side effects than traditional chemotherapy. But they are so specialized that only a limited subset of lung cancer patients qualifies for participation. The immunotherapy drug nivolumab, for example, is approved for patients with non-squamous non-small cell lung cancer who have already tried platinum-based chemotherapy or EGFR- or ALK-targeted agents. Advanced genomic testing may determine whether you are a candidate. Other factors—such as your cancer mutations and stage, how you have responded to past treatments and other individual considerations—may also determine whether you qualify for specific trials.

Are they only available to patients who have exhausted other lung cancer treatment options?

Lung cancer patients may qualify to participate in a clinical trial at any stage of their treatment journey. Some patients may join a clinical trial when they first start treatment, in conjunction with standard therapy, on the chance it may offer better results. Other trials are designed for lung cancer patients who have not responded adequately to conventional treatments. Your Lung Cancer Center oncologist will discuss the options and risks, and explain the various protocols involved.

How does CTCA select the trials it offers?

At CTCA, our Lung Cancer Center experts are always searching for innovative ways to treat lung cancer. Offering carefully selected clinical trials when appropriate helps us fulfill that mission. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Our oncologists decide to participate as a clinical trial site only after careful consideration of the relative benefit to patients.

How do I find out whether a specific clinical trial may benefit me?

Your Lung Cancer Center oncologist and care team may recommend a trial depending on your individual needs and treatment goals. Learn more about ongoing clinical trials at CTCA. For general questions, contact an Oncology Information Specialist at 888-841-9129.

Cancer Treatment Centers of America Locations, Phoenix – CTCA

Where we are located

CTCA Phoenix

Lung Cancer Center
14200 W. Celebrate Life Way
Goodyear, AZ 85338
New Patients: 833-650-7781
Current Patients:: 888-357-CTCA

New research

Offering clinical trials on new and emerging cancer treatment options.

View our clinical trials

What’s your risk?

Assess your cancer risk and take control

Assess your cancer risk

Insurance plans

We accept a wide range of insurance plans.

Verify your insurance